RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
The most common chronic myeloproliferative disorder characterized by neutrophilic leukocytosis. It is associated with the Philadelphia (Ph) chromosome and/or the BCR/ABL fusion gene. Most patients are middle-aged or elderly. Common findings at presentation include fatigue, weight loss, anemia, night sweats, and splenomegaly. The disease is bi- or triphasic: an initial indolent chronic phase is followed by accelerated or blast phase. Allogeneic bone marrow transplantation is currently the only curative therapy (adapted from WHO 2001).
View Complete Description Individual Studies |
|
|---|---|
|
|
Authors: Yaoyu Chen, Yiguo Hu, Haojian Zhang, Cong Peng, Shaoguang Li
Nature genetics 2009 JulAuthors: Ingo Roeder, Matthias Horn, Ingmar Glauche, Andreas Hochhaus, Martin C Mueller, Markus Loeffler
Nature medicine 2006 OctThought leaders and organizations working on research involving chronic myeloid leukemia.
conditions: Chronic Myeloid Leukemia
interventions: SV40 vectors carrying siRNA
conditions: Chronic Myeloid Leukemia
interventions: Imatinib mesylate 600mg/day ; Peg-Interféron at 90 microg/week
Praticien Hospitalier
University Hospital
No NextBio groups were found for “chronic myeloid leukemia”.
Be the first to
start
a group and share your interests with others within the NextBio community.